MTIP
CTIC

Magee Thomson Investment Partners’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Magee Thomson Investment Partners’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-238
Closed -$4K – 119
2015
Q4 		$4K Hold
238
– – ﹤0.01% 91
2015
Q3 		$4K Hold
238
– – ﹤0.01% 97
2015
Q2 		$5K Hold
238
– – ﹤0.01% 84
2015
Q1 		$4K Sell
238
-1,910
-89% -$43K ﹤0.01% 98
2014
Q4 		$50K Hold
2,148
– – 0.01% 93
2014
Q3 		$51K Sell
2,148
-28
-1% -$728 0.01% 94
2014
Q2 		$60K Buy
2,176
+33
+2% +$992 0.01% 95
2014
Q1 		$71K Buy
2,143
+1,939
+950% +$66.3K 0.02% 93
2013
Q4 		$4K Buy
+204
New +$3.71K ﹤0.01% 145

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return